Contract analysis

I. Executive Summary The purpose of this memorandum is to set forth the proposed staffing plan, workstream assignments, and estimated budget for Calderwood & Harkness LLP's representation of Ardent Capital Partners III LP ("Ardent Capital" or the "Buyer") in its proposed acquisition of Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Target") for an aggregate equity value of $2,800,000,000 (the "Transaction"

II. Transaction Overview Set forth below is a summary of the principal terms and parties to the Transaction, as currently understood, for the purpose of informing staffing assignments and budget estimates. Buyer. Ardent Capital Partners III LP is a Delaware limited partnership (Fund III, vintage 2023, with total committed capital of $12.5 billion). The general partner of Ardent Capital Partners III LP is Ardent Capit

III. Workstream Identification Set forth below is an outline of the principal legal workstreams that Calderwood & Harkness will handle or coordinate in connection with the Transaction. Each workstream is described in sufficient detail to inform staffing assignments and budget estimation. The workstreams are interrelated, and staffing assignments will require close coordination among team members, as described further

1. Agreement and Plan of Merger. Negotiation and drafting of the Merger Agreement, including representations and warranties, covenants (interim operating covenants, efforts covenants for regulatory approvals, cooperation covenants, access covenants), conditions to closing, termination provisions (including reverse termination fee and expense reimbursement mechanics), indemnification (to the extent not subsumed by R&W

2. Disclosure Schedules. Preparation and negotiation of the Buyer's disclosure schedules to the Merger Agreement. While the Target will prepare its own disclosure schedules, Calderwood & Harkness will coordinate the Buyer's review and negotiation of the Target's schedules and will prepare the Buyer's schedules (principally relating to the organization and authority of Apex Holdings and Merger Sub, financing, and requ

3. Ancillary Corporate Documents. Preparation of the Certificate of Merger to be filed with the Secretary of State of the State of Delaware; the Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws of the surviving corporation; board resolutions and written consents of the sole stockholder of Merger Sub (Apex Holdings) and the sole stockholder of Apex Holdings (Ardent Capital Partners III

4. No-Shop Compliance Procedures and Fiduciary-Out Monitoring. The Merger Agreement is expected to contain customary no-shop provisions governing the Target's conduct with respect to competing acquisition proposals. While the primary compliance obligation rests with the Target and its counsel, Calderwood & Harkness will advise the Buyer with respect to monitoring compliance, evaluating any "superior proposal" notific

5. Escrow Agreement. Negotiation and drafting of the Escrow Agreement with Continental Fiduciary Trust Company as escrow agent, providing for a $140,000,000 escrow fund (representing 5.0% of the aggregate equity value) for an 18-month post-closing period to support indemnification claims. The account reference is CFT-ESC-2025-7894. The escrow fund, together with the R&W insurance policy, will serve as the primary rec

6. Paying Agent Agreement. Negotiation and drafting of the Paying Agent Agreement with Atlas Shareholder Services Inc. as paying agent, governing the exchange of Target shares for the per-share merger consideration and the processing of letters of transmittal.

7. Letter of Transmittal. Preparation of the form of letter of transmittal to be distributed to Target stockholders in connection with the exchange of their shares for merger consideration.

8. Closing Deliverables. Preparation of all Buyer-side closing deliverables, including officer's certificates, secretary's certificates, certified copies of organizational documents, good standing certificates for Apex Holdings and Merger Sub, the FIRPTA certificate, W-9 coordination for the paying agent, and other customary closing deliverables.

9. Funds Flow Preparation and Closing Mechanics. Coordination and preparation of the funds flow memorandum, detailing the sources and uses of funds at closing, wire transfer instructions, and the sequencing of all closing payments (including financing proceeds, equity contributions, rollover share exchanges, escrow deposits, expense payments, and paying agent funding).

10. Seller's Counsel Correspondence. Day-to-day correspondence and negotiation with seller's counsel at Caldwell, Raines & Sheppard LLP, led by Patricia Okonkwo and Daniel Feinberg, including turn management, issues lists, and resolution of open points.

11. Financial Advisor Coordination. Coordination with the Buyer's financial advisor, Whitfield Partners LLC (Christopher Brennan), including review of sources and uses, transaction economics, and financial advisor deliverables. B. Due Diligence This workstream encompasses the comprehensive legal due diligence investigation of the Target and its subsidiaries, including:

1. Due Diligence Request List. Preparation and delivery of a comprehensive due diligence request list to the Target and its counsel, covering all standard categories as well as deal-specific areas of focus (procurement-automation technology, government contracts, data security, international operations).

2. Corporate and Organizational Diligence. Review of the corporate organizational documents, minute books, stockholder records, equity capitalization tables, and organizational charts for Luminex Holdings and each of its subsidiaries across all five jurisdictions. This will include verification of the 2021 reorganization pursuant to which Luminex Systems AG was placed below Luminex Holdings as a Delaware holding comp

4. Material Contracts Review. Review of approximately 340 commercial contracts, with particular focus on the approximately 26 enterprise license agreements that contain change of control provisions. This review will be conducted in coordination with the change of control consent tracker described below and will also encompass vendor contracts, partnership agreements, reseller arrangements, and government contracts.

5. Change of Control / Consent Tracker. Preparation and maintenance of a comprehensive tracker identifying all contracts, licenses, permits, and other arrangements that contain change of control provisions, anti-assignment clauses, or consent requirements triggered by the Transaction. The tracker will categorize items by risk level (critical path, high priority, moderate priority, low risk) and will be used to coordi

6. Employment and Benefits Diligence. Review of employment arrangements across all jurisdictions, including executive employment agreements, offer letter templates, employee handbooks, equity incentive plans (including option and RSU plans and award agreements), severance and change of control arrangements, Swiss social insurance compliance, German works council consultation requirements, and global benefit plans.

7. Litigation and Regulatory Diligence. Review of pending and threatened litigation, governmental investigations, consent decrees, and regulatory compliance matters, including data privacy and security compliance (GDPR, CCPA, PDPA) and government contract compliance.

8. Real Property and Leases Diligence. Review of the Target's real property interests, including the headquarters lease at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191, and office leases in Zürich, Munich, London, and Singapore. This will include review of lease terms, assignment and subletting restrictions, renewal options, and any change of control provisions. C. Antitrust and Regulatory This workstream e

1. HSR Act Premerger Notification. Preparation and filing of the HSR premerger notification form with the Federal Trade Commission ("FTC") and the Antitrust Division of the U.S. Department of Justice ("DOJ"). The anticipated filing date is March 28, 2025. The assigned transaction number is HSR-20250328-4192. The filing fee, based on the 2025 HSR fee schedule and the $2.8 billion transaction value tier, is $2,390,000.

2. Second Request Preparation and Response Strategy. Based on the combined market share of approximately 25% in the procurement-automation SaaS market (Luminex Holdings approximately 18% and Vectis Solutions LLC approximately 7%), we anticipate a meaningful probability that the FTC will issue a Second Request for additional information and documentary material. We estimate that a Second Request, if issued, would like

3. FTC Timing Agreement Negotiation. If a Second Request is issued, Calderwood & Harkness will negotiate a timing agreement with FTC staff governing the process and timeline for substantial compliance, including any pull-and-refile strategy if appropriate.

4. Antitrust Risk Assessment and Remedies/Divestiture Analysis. Calderwood & Harkness will prepare a comprehensive antitrust risk assessment addressing the competitive overlap between Luminex Holdings and Vectis Solutions LLC, an existing Ardent Capital portfolio company (CEO Michael Parekh; 2024 revenue of $68,000,000). If remedies are required to obtain regulatory clearance, Calderwood & Harkness will advise on pot

5. CFIUS Voluntary Joint Notice. Preparation and filing of a voluntary joint notice with the Committee on Foreign Investment in the United States. The anticipated filing date is April 4, 2025, and the assigned tracking number is CFIUS-2025-0087. The initial 45-day review period is expected to expire on or about May 19, 2025. CFIUS review is warranted due to the Target's contracts with the U.S. Department of Defense (

6. CFIUS Mitigation Strategy. If CFIUS identifies national security concerns, Calderwood & Harkness will advise on and negotiate any mitigation measures, which could include proxy board arrangements, data security protocols, access restrictions for non-U.S. personnel, and compliance monitoring mechanisms.

7. Coordination of Foreign Filings with Local Counsel. Calderwood & Harkness will coordinate the following foreign regulatory filings through local counsel: • Swiss FINMA/SECO / Competition Filing (File No. 32-0973). Breitfeld Hess & Partner AG (Dr. Lukas Breitfeld, lead partner) will prepare and file the Swiss competition notification under the Swiss Cartel Act (KartG) and the SECO/Lex Koller notification. Breitfeld

8. Regulatory Conditions and Timetable Tracking. Calderwood & Harkness will prepare and maintain a comprehensive regulatory conditions and timetable tracker, monitoring all filing deadlines, review periods, waiting periods, and clearance milestones across all jurisdictions. D. Financing. This workstream encompasses all debt and equity financing documentation for the Transaction, including:

1. Commitment Letter. Review and negotiation of the commitment letter from Stonebridge Credit Partners LLC (Reference No. SC-2025-0312-AC, dated March 8, 2025) committing to provide the senior secured credit facility described below. Calderwood & Harkness will ensure that the "certain funds" provisions, market flex terms, and conditions to funding are appropriately aligned with the conditions to closing under the Mer

2. Fee Letter. Review of the fee letter associated with the commitment letter, including arrangement fees, upfront fees, and syndication economics.

3. Credit Agreement. Drafting and negotiation of the definitive credit agreement governing the $1,400,000,000 senior secured credit facility, consisting of (a) a $1,200,000,000 Term Loan B bearing interest at SOFR plus 475 basis points, with a seven-year maturity and 1.00% original issue discount, and (b) a $200,000,000 revolving credit facility bearing interest at SOFR plus 425 basis points, with a five-year maturit

4. Guarantee and Collateral Agreement. Drafting and negotiation of the guarantee and collateral agreement providing for a first-priority lien on substantially all domestic assets of the surviving corporation and its domestic subsidiaries, together with a 65% pledge of the equity interests in first-tier foreign subsidiaries.

5. Intercreditor Agreement. Drafting and negotiation of the intercreditor agreement between Stonebridge Credit Partners LLC (as senior representative) and Crestline Mezzanine Partners II LP (as subordinated representative), establishing the priority, standstill, and turnover provisions governing the relationship between the senior secured credit facility and the mezzanine facility described below.

6. Subordinated Note Purchase Agreement. Drafting and negotiation of the note purchase agreement governing the $300,000,000 subordinated mezzanine facility provided by Crestline Mezzanine Partners II LP, bearing interest at 11.5% with PIK toggle, with an eight-year maturity and 2.0% warrant coverage.

7. Mezzanine Warrant Agreement. Drafting and negotiation of the warrant agreement to be issued to Crestline Mezzanine Partners II LP in connection with the mezzanine facility, providing for warrants to purchase 2.0% of the fully diluted equity of Apex Holdings on a post-closing basis.

8. Equity Commitment Letter. Drafting and negotiation of the equity commitment letter from Ardent Capital Partners III LP committing to fund $695,980,000 in equity to Apex Holdings at closing.

9. Co-Investment Agreements. Drafting and negotiation of the co-investment agreements with the following co-investors: • Northvale Sovereign Holdings Ltd. — $200,000,000 equity co-investment; contact: Ahmad Al-Rashid • Summit Ridge Capital Partners LP — $100,000,000 equity co-investment; contact: Karen Lindstrom

10. Conditions Precedent Tracking and Lender Communication. Preparation and maintenance of a conditions precedent checklist for the financing, and ongoing communication with counsel for the lenders (to be identified) regarding satisfaction of funding conditions. E. Rollover and Equity / Employment This workstream encompasses the management rollover arrangements, post-closing equity governance, and key employment agre

1. Rollover Agreements. Drafting and negotiation of the form of rollover agreement for management participants who will contribute a portion of their Luminex Holdings equity to Apex Holdings in exchange for equity in the post-closing entity rather than receiving cash merger consideration. The principal rollover participants are as follows:

2. Post-Closing Stockholders Agreement. Drafting and negotiation of the stockholders agreement for Ardent Apex Holdings Inc. that will govern the equity relationships among Ardent Capital Partners III LP, the management rollover participants, Northvale Sovereign Holdings Ltd., and Summit Ridge Capital Partners LP following the closing. The stockholders agreement will address governance (board composition, observer ri

3. Registration Rights Agreement. Drafting and negotiation of the registration rights agreement providing the equity holders with customary demand, piggyback, and S-3 shelf registration rights in connection with any future public offering or other registered transaction.

4. Management Equity Incentive Plan. Drafting and negotiation of the post-closing management equity incentive plan, which is expected to include options and/or profits interests representing approximately 8–10% of the fully diluted equity of Apex Holdings, with customary time-based and performance-based vesting schedules.

5. Employment Agreements. Drafting and negotiation of the employment agreements for Dr. Stefan Kessler (CEO) and Annelise Gruber (CFO), setting forth the terms of their continued employment with the surviving corporation and its subsidiaries following the closing, including base compensation, annual bonus, long-term incentive awards, benefits, severance protections, restrictive covenants (non-competition, non-solicit

1. Section 338(h)(10) Election Analysis. Analysis of the availability and advisability of a joint election under Section 338(h)(10) of the Internal Revenue Code, which would treat the stock acquisition as a deemed asset purchase for federal income tax purposes. Based on preliminary analysis, the election would result in an estimated tax basis step-up of approximately $620,000,000 in amortizable intangible assets, gen

2. Swiss Withholding Tax Analysis. Analysis of Swiss withholding tax implications, including the statutory 35% withholding rate on dividends and other distributions from Luminex Systems AG, the reduced 5% treaty rate available under the U.S.-Switzerland Income Tax Treaty (assuming eligibility), and the limitation-on-benefits article requirements that Apex Holdings must satisfy to claim treaty benefits.

3. Transfer Pricing Restructuring. Analysis and implementation of a revised intercompany transfer pricing structure, pursuant to which the existing royalty rate of 4.5% of U.S. net revenues (paid by Luminex Systems Inc. to Luminex Systems AG for the use of intellectual property) would be adjusted to 6.0% of U.S. net revenues. This adjustment will be supported by a benchmark study to be prepared by Pendleton & Associa

4. State and Local Tax Considerations. Analysis of state and local tax implications of the Transaction structure, including considerations in Delaware, Virginia, California, and any other states in which the Target or its subsidiaries have nexus.

5. FIRPTA / NRA Withholding Analysis. Analysis of Foreign Investment in Real Property Tax Act ("FIRPTA") withholding obligations and nonresident alien withholding requirements in connection with payments to any non-U.S. holders of Luminex Holdings common stock.

6. Tax Provisions Review and Markup in Merger Agreement. Review and negotiation of all tax-related provisions in the Merger Agreement, including tax representations and warranties, pre-closing tax covenants, tax indemnification provisions, and post-closing tax cooperation. The tax survival period in the Merger Agreement is expected to be set at 60 days following the expiration of the applicable statute of limitations

7. Coordination with Pendleton & Associates LLP. Close coordination with Pendleton & Associates LLP (Richard Chow, engagement partner), which serves as the Buyer's tax and accounting advisor, on purchase price allocation, Section 338(h)(10) election mechanics, transfer pricing benchmarking, and quality of earnings analysis. G. Insurance. This workstream encompasses the placement and documentation of transaction-relat

1. Representations and Warranties Insurance. Coordination with Ashbury Risk Advisors LLC (Philip Navarro), the Buyer's insurance broker, on the placement of a buyer-side representations and warranties insurance policy. The carrier is Grandview Specialty Insurance Company (Policy No. GSI-RWI-2025-04821). The key terms are as follows: aggregate policy limit of $420,000,000 (representing 15.0% of the aggregate equity va

2. Directors and Officers Tail Policy. Procurement of a D&O tail policy for the Target's pre-closing directors and officers, as required under the Merger Agreement. The carrier is Palisade Mutual Insurance Co. (Policy No. PAL-DO-2025-11473), with an aggregate limit of $50,000,000 and a six-year tail period. Calderwood & Harkness will review the policy terms and ensure compliance with the Merger Agreement's indemnific

1. Calderwood & Harkness Legal Opinion. Preparation and delivery of Calderwood & Harkness's legal opinion to the Target and the Sellers at closing, addressing the enforceability of the Merger Agreement, due authorization and execution by Apex Holdings and Merger Sub, and the organization and good standing of Apex Holdings and Merger Sub under Delaware law. 2. 10b-5 Negative Assurance Letter. If required by Stonebridg

3. Solvency Certificate. Preparation of the form of solvency certificate to be delivered by the Chief Financial Officer of the surviving corporation at closing, certifying the solvency of the surviving corporation and its subsidiaries on a consolidated basis after giving effect to the Transaction and the related financing.

IV. Staffing Plan A. Core Team — Calderwood & Harkness LLP, New York Office The following table sets forth the core team members assigned to the Transaction, together with their primary workstream responsibilities, estimated hours, and billing rates. All core team members are based in Calderwood & Harkness's New York office at 7 Times Square, New York, NY 10036. The estimated hours represent the total hours anticipat

V. Budget Estimate — Calderwood & Harkness Legal Fees A. Fee Estimate by Workstream Set forth below is the estimated range of Calderwood & Harkness legal fees by workstream for the Transaction, from engagement opening through closing and a reasonable post-closing period. The fee estimates are based on the staffing plan described in Section IV and the workstream descriptions in Section III, and reflect the billing rat

VI. Estimated Total Buyer Transaction Expenses Ardent Capital's estimated total buyer transaction expenses budget is $62,000,000, inclusive of all legal, financial advisory, accounting, insurance, regulatory filing, and related costs. The estimated allocation of this budget across expense categories is set forth in the following table. This section is provided for context to allow the Calderwood & Harkness team to un

VII. Billing Arrangements The billing arrangements for this engagement are governed by the engagement letter between Calderwood & Harkness LLP and Ardent Capital Partners III LP dated March 10, 2025, and are summarized below for reference. Billing Partner. Sandra Tung is the designated billing partner for this matter. All invoices will be reviewed and approved by Sandra Tung prior to delivery to the client. Billing C

VIII. Key Assumptions and Risk Factors Affecting Budget The budget estimates set forth in this memorandum are based on a number of assumptions regarding the scope and complexity of the Transaction, as well as the regulatory and deal-execution timeline. Set forth below are the principal risk factors that could cause actual fees and expenses to exceed the budget estimates. A. Regulatory Risk The most significant source